Press Releases

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, announced that United Healthcare has updated its cardiac imaging guidelines to fully align with recent recommendations from radiology benefit manager EviCore. United Healthcare’s new guidelines now include coronary computed tomography angiography (CTA) plaque quantification (see page 520), specifically encompassing Elucid&r

BDC Laboratories, a leader in cardiovascular device testing solutions, recently announced a strategic partnership with the newly established Dilawri Cardiovascular Institute (DCI). Together, the organizations aim to enhance the development and clinical validation of cardiovascular medical devices. DCI features 16 core centers that bridge research with all areas of cardiac practice. The collaboration coincides with the launch of DCI's Center for Cardiovascular Translational Scien

SeaStar Medical Holding Corporation a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has successfully reached enrollment of 125 patients in the NEUTRALIZE-AKI pivotal clinical trial. Additionally, it has activated Methodist Hospital Metropolitan of San Antonio, Texas, as its 16th clinical trial site. The company also reported that it remains on track to r

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment (NTAP) for the ShortCut™ device, effective October 1, 2025. The NTAP designation recognizes ShortCut™ as a breakthrough technology that addresses a critical unmet need in valve-in-valve transcatheter aortic valve replacement (TAVR) by enabling treatmen

Aetrex, Inc., a global leader in foot scanning technology and data-driven orthotics and footwear, today announced the launch of the Zoe Pro 3D foot scanner—a technology advancement designed to make premium foot scanning affordable and accessible to retailers of all sizes. Launching this August, Zoe Pro combines 3D foot measurements, underfoot pressure analysis, and AI-driven product recommendations in a compact, intuitive system. Built for modern retail, it allows stores to deliver accu

Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) designed to advance laboratory automation and data-driven infectious disease monitoring. The company introduced CURECA™, world's first fully unattended PCR automation system, and STAgora™, a real-time data analytics platform intended to support earlier detection and precision care. Chairman Highlights Next Step in Molecular Diagnostics

Roche today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the cobas® Respiratory 4-flex. This is the first FDA-cleared assay utilizing Roche's innovative TAGS (Temperature-Activated Generation of Signal) technology, designed to streamline respiratory testing, and to ensure timely and accurate diagnoses for patients. The new test provides accurate PCR results for the four most common respiratory viruses: SARS-CoV-2, influenza A, influenza B and re

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s SetPoint System, a breakthrough innovation for people with rheumatoid arthritis (RA). The SetPoint System is a first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe RA who are not adequately managed by—or cannot tolerate&mdash

Ultromics, a pioneer in AI-driven cardiology solutions, today announced it has raised $55 million in Series C financing. The round was co-led by L&G, Allegis Capital and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture Fund and Oxford University. Major U.S. health systems, including UChicago Medicine's venture investment vehicle, UCM Ventures, and UPMC Enterprises also participated in the round. Built on years of clinical study and hundreds

Life Backup Plan by Galacxia, Inc, redefining how individuals and care systems manage everything from emergencies to healthcare communication, today announced $45,000 in new funding. The investment will support the app’s national rollout and fuel development of features aimed at improving emergency response, streamlining care coordination, and lowering healthcare costs. “Life Backup Plan began as a safety net for people alone during vulnerable moments—seniors, solo